Clinical Trials in Colorado

Showing 2381-2400 of 15,592 trials

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT06919666

Fixed dose NT219 weekly plus pembrolizumab every 3 weeks or cetuximab weekly to be continued until progression, unacceptable toxicity, or investigator or participant decision.

Head and Neck CancerHead and Neck Squamous Cell Carcinoma

University of Colorado, Denver29 participantsStarted Jun 2025

Aurora, Colorado, United States • Highlands Ranch, Colorado, United States

Active Not RecruitingPhase 343 miles

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03568318

The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of adolescent and adult participants with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.

Atopic Dermatitis

AbbVie1,533 participantsStarted Aug 2018

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +190 more locations

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Find Trials by Condition in Colorado

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Ribociclib and Letrozole Treatment in Ovarian Cancer

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Lumbar Interbody Implant Study

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease